Methuselah Co., set up in Yamagata in June 2016, has developed technology to produce autologous fibroblast cells, a cell type which which can be blended with other functional cells to develop regenerative medicine of various types.
BioImpact news release, July 7, 2016
Keio University spins out venture Methuselah, aiming at fibroblast production